SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-009806
Filing Date
2020-02-03
Accepted
2020-02-03 16:43:20
Documents
72
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv537248-10q.htm 10-Q 1295960
2 EXHIBIT 31.1 tv537248-exh31x1.htm EX-31.1 6783
3 EXHIBIT 31.2 tv537248-exh31x2.htm EX-31.2 6765
4 EXHIBIT 32.1 tv537248-exh32x1.htm EX-32.1 2863
5 EXHIBIT 32.2 tv537248-exh32x2.htm EX-32.2 2843
  Complete submission text file 0001104659-20-009806.txt   8234171

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pahc-20191231_lab.xml EX-101.LAB 359717
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pahc-20191231_pre.xml EX-101.PRE 329076
8 XBRL INSTANCE DOCUMENT pahc-20191231.xml EX-101.INS 2499824
9 XBRL TAXONOMY EXTENSION SCHEMA pahc-20191231.xsd EX-101.SCH 43727
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pahc-20191231_cal.xml EX-101.CAL 79560
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pahc-20191231_def.xml EX-101.DEF 150105
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36410 | Film No.: 20569201
SIC: 2834 Pharmaceutical Preparations